STERIS (STE) Expected to Announce Quarterly Earnings on Wednesday

STERIS (NYSE:STE - Get Free Report) is expected to be posting its Q1 2026 quarterly earnings results after the market closes on Wednesday, August 6th. Analysts expect STERIS to post earnings of $2.32 per share and revenue of $1.36 billion for the quarter. STERIS has set its FY 2026 guidance at 9.900-10.150 EPS.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 EPS for the quarter, topping analysts' consensus estimates of $2.59 by $0.15. The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.47 billion. STERIS had a net margin of 11.26% and a return on equity of 14.21%. The firm's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.58 earnings per share. On average, analysts expect STERIS to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

STERIS Stock Up 0.4%

STERIS stock traded up $0.91 during trading hours on Wednesday, reaching $229.28. The stock had a trading volume of 408,063 shares, compared to its average volume of 618,241. The company has a market cap of $22.55 billion, a price-to-earnings ratio of 36.98 and a beta of 0.92. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.96 and a quick ratio of 1.39. The business's 50 day moving average price is $236.57 and its 200-day moving average price is $227.69. STERIS has a 52 week low of $200.98 and a 52 week high of $252.79.

STERIS Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 26th. Shareholders of record on Thursday, September 4th will be issued a $0.63 dividend. This is an increase from STERIS's previous quarterly dividend of $0.57. This represents a $2.52 dividend on an annualized basis and a yield of 1.10%. STERIS's payout ratio is currently 36.77%.

Insider Transactions at STERIS

In other STERIS news, SVP Cary L. Majors sold 12,828 shares of STERIS stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $250.08, for a total value of $3,208,026.24. Following the completion of the transaction, the senior vice president directly owned 11,372 shares of the company's stock, valued at $2,843,909.76. The trade was a 53.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Daniel A. Carestio sold 17,626 shares of STERIS stock in a transaction on Thursday, June 5th. The shares were sold at an average price of $242.56, for a total value of $4,275,362.56. Following the completion of the transaction, the chief executive officer owned 51,385 shares of the company's stock, valued at approximately $12,463,945.60. This trade represents a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.07% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On STERIS

A number of institutional investors and hedge funds have recently made changes to their positions in STE. Geneos Wealth Management Inc. boosted its holdings in shares of STERIS by 416.0% in the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 104 shares during the period. Empowered Funds LLC increased its position in STERIS by 16.1% during the 1st quarter. Empowered Funds LLC now owns 2,303 shares of the medical equipment provider's stock worth $522,000 after purchasing an additional 319 shares during the period. Jones Financial Companies Lllp increased its position in STERIS by 46.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,106 shares of the medical equipment provider's stock worth $251,000 after purchasing an additional 349 shares during the period. Woodline Partners LP increased its position in STERIS by 40.0% during the 1st quarter. Woodline Partners LP now owns 8,300 shares of the medical equipment provider's stock worth $1,881,000 after purchasing an additional 2,372 shares during the period. Finally, Jane Street Group LLC increased its position in STERIS by 38.9% during the 1st quarter. Jane Street Group LLC now owns 20,716 shares of the medical equipment provider's stock worth $4,695,000 after purchasing an additional 5,803 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on STE shares. JMP Securities upped their price objective on shares of STERIS from $265.00 to $280.00 and gave the company a "market outperform" rating in a report on Friday, May 16th. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Monday, April 7th. Morgan Stanley upgraded shares of STERIS from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $260.00 to $276.00 in a report on Tuesday, July 15th. Jefferies Financial Group initiated coverage on shares of STERIS in a report on Thursday, May 29th. They issued a "hold" rating and a $263.00 price target on the stock. Finally, Stephens reiterated an "overweight" rating and set a $250.00 target price on shares of STERIS in a research report on Thursday, May 15th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, STERIS presently has a consensus rating of "Moderate Buy" and a consensus price target of $270.33.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.